Literature DB >> 3001046

Ouabain binding sites and (Na+,K+)-ATPase activity in rat cardiac hypertrophy. Expression of the neonatal forms.

D Charlemagne, J M Maixent, M Preteseille, L G Lelievre.   

Abstract

The adaptation of the myocardium to mechanical overload which results in cardiac hypertrophy involves several membrane functions. The digitalis receptor in sarcolemma vesicles from hypertrophied rat hearts is characterized by binding of [3H]ouabain and ouabain-induced inhibition of (Na+,K+)-ATPase. The results show the existence of two families of ouabain binding sites with apparent dissociation constants (Kd) of 1.8-3.2 X 10(-8) M and 1-8 X 10(-6) M, respectively, which are similar to those found in normal hearts. The presence of the high affinity receptor in hypertrophied rat heart is correlated to a detectable inhibition of the (Na+,K+)-ATPase (IC50 = 1-3 X 10(-8) M). However, the high and low affinity sites in hypertrophied hearts bind and release ouabain at 4-5-fold slower rates than the corresponding sites in normal hearts. These properties are similar to that we observed in newborn rat cardiac preparations. Taken together with the expression of myosin isoforms (Schwartz, K., Lompre, A.M., Bouveret, P., Wisnewsky, C., and Whalen, R.G. (1982) J. Biol. Chem. 23, 14412-14418), our data show that the physiological adaptation of the heart also involves the resurgence of the neonatal forms of the digitalis receptor.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3001046

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Rat cardiac ventricle has two Na+,K+-ATPases with different affinities for ouabain: developmental changes in immunologically different catalytic subunits.

Authors:  K J Sweadner; S K Farshi
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

2.  The cardiac conduction system in the rat expresses the alpha 2 and alpha 3 isoforms of the Na+,K(+)-ATPase.

Authors:  R Zahler; M Brines; M Kashgarian; E J Benz; M Gilmore-Hebert
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

3.  Thyroidal enhancement of rat myocardial Na,K-ATPase: preferential expression of alpha 2 activity and mRNA abundance.

Authors:  G G Gick; J Melikian; F Ismail-Beigi
Journal:  J Membr Biol       Date:  1990-05       Impact factor: 1.843

Review 4.  Energy requirements of contraction and relaxation: implications for inotropic stimulation of the failing heart.

Authors:  A M Katz
Journal:  Basic Res Cardiol       Date:  1989       Impact factor: 17.165

5.  Tissue specificity, localization in brain, and cell-free translation of mRNA encoding the A3 isoform of Na+,K+-ATPase.

Authors:  J W Schneider; R W Mercer; M Gilmore-Hebert; M F Utset; C Lai; A Greene; E J Benz
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

6.  A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophic growth program.

Authors:  M N Sack; D L Disch; H A Rockman; D P Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

Review 7.  Regulation of Na+,K(+)-ATPase gene expression: a model to study terminal differentiation.

Authors:  G Celsi; Z M Wang
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

Review 8.  Gene regulatory mechanisms governing energy metabolism during cardiac hypertrophic growth.

Authors:  John J Lehman; Daniel P Kelly
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

9.  Diminished toxicity of ouabain in the hypertrophied rat heart.

Authors:  B Chevalier; I Berrebi-Bertrand; C Mouas; L G Lelièvre; B Swynghedauw
Journal:  Pflugers Arch       Date:  1989-07       Impact factor: 3.657

10.  Na, K-ATPase isoform gene expression in normal and hypertrophied dog heart.

Authors:  R Zahler; M Gilmore-Hebert; W Sun; E J Benz
Journal:  Basic Res Cardiol       Date:  1996 May-Jun       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.